One COVID-19 vaccine in development may be ready for review in December. Managers at Novavax say they are now enrolling volunteers for a second phase of clinical trials. The data should be ready for assessment within a few months. Phase 1 data showed the two-dose vaccine in healthy adults producing …
Read More »Based on history, COVID-19 vaccine is likely to produce some kind of negative reaction
